Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Circulation ; 115(9): 1101-8, 2007 Mar 06.
Article in English | MEDLINE | ID: mdl-17339568

ABSTRACT

BACKGROUND: Chagas disease is a major cause of morbidity and mortality in Latin America. Knowledge of the predictors of prognosis can help clinical decision making by identifying patients' level of risk. METHODS AND RESULTS: We reviewed the published literature on prognostic factors in patients with Chagas disease by performing a PubMed search for articles published in any language between 1985 and February 2006 and hand searches of the reference lists of retrieved articles. Studies were selected if they included patients in the chronic phase of Chagas disease, analyzed a clearly defined outcome (all-cause mortality, sudden cardiac deaths, and/or cardiovascular deaths), and used multivariable regression models of prognosis. From 606 potentially relevant studies, 12 met the inclusion criteria: 8 clinic-based studies including 3928 patients and 4 hospital-based studies including 349 patients. Impaired left ventricular function by echocardiogram or cineventriculogram was found to be the most common and consistent independent predictor of death. New York Heart Association functional class III/IV and cardiomegaly on the chest radiography also were independently associated with higher mortality. More recently, strong evidence was found that nonsustained ventricular tachycardia on 24-hour Holter monitoring indicated an adverse prognosis. The typical ECG abnormalities showed limited additional prognostic value. Other often-mentioned risk factors, advanced age and male sex, showed inconsistent results. A formal meta-analysis was not feasible because of the heterogeneity of published studies and the lack of minimal standards in reporting results. CONCLUSIONS: A systematic review of published studies indicates that impaired left ventricular function, New York Heart Association class III/IV, cardiomegaly, and nonsustained ventricular tachycardia indicate a poor prognosis in patients with chronic Chagas disease.


Subject(s)
Chagas Disease/mortality , Adult , Aged , Algorithms , Cardiomegaly/epidemiology , Cardiomegaly/etiology , Case Management , Chagas Cardiomyopathy/complications , Chagas Cardiomyopathy/mortality , Chronic Disease , Death, Sudden, Cardiac/epidemiology , Electrocardiography , Electrocardiography, Ambulatory , Female , Follow-Up Studies , Heart Failure/epidemiology , Heart Failure/etiology , Humans , Kaplan-Meier Estimate , Latin America/epidemiology , Male , Middle Aged , Multivariate Analysis , Prognosis , Radiography , Risk , Tachycardia, Ventricular/epidemiology , Tachycardia, Ventricular/etiology , Ultrasonography , Ventricular Dysfunction, Left/diagnostic imaging , Ventricular Dysfunction, Left/epidemiology , Ventricular Dysfunction, Left/etiology
2.
N Engl J Med ; 355(8): 799-808, 2006 Aug 24.
Article in English | MEDLINE | ID: mdl-16928995

ABSTRACT

BACKGROUND: Chagas' disease is an important health problem in Latin America, and cardiac involvement is associated with substantial morbidity and mortality. We developed a model to predict the risk of death in patients with Chagas' heart disease. METHODS: We retrospectively evaluated 424 outpatients from a regional Brazilian cohort. The association of potential risk factors with death was tested by Cox proportional-hazards analysis, and a risk score was created. The model was validated in 153 patients from a separate community hospital. RESULTS: During a mean follow-up of 7.9 years, 130 patients in the development cohort died. Six independent prognostic factors were identified, and each was assigned a number of points proportional to its regression coefficient: New York Heart Association class III or IV (5 points), evidence of cardiomegaly on radiography (5 points), left ventricular systolic dysfunction on echocardiography (3 points), nonsustained ventricular tachycardia on 24-hour Holter monitoring (3 points), low QRS voltage on electrocardiography (2 points), and male sex (2 points). We calculated risk scores for each patient and defined three risk groups: low risk (0 to 6 points), intermediate risk (7 to 11 points), and high risk (12 to 20 points). In the development cohort, the 10-year mortality rates for these three groups were 10 percent, 44 percent, and 84 percent, respectively. In the validation cohort, the corresponding mortality rates were 9 percent, 37 percent, and 85 percent. The C statistic for the point system was 0.84 in the development cohort and 0.81 in the validation cohort. CONCLUSIONS: A simple risk score was developed to predict death in Chagas' heart disease and was validated in an independent cohort.


Subject(s)
Chagas Cardiomyopathy/mortality , Risk Assessment , Adult , Analysis of Variance , Animals , Arrhythmias, Cardiac/etiology , Brazil/epidemiology , Bundle-Branch Block/etiology , Chagas Disease/complications , Chagas Disease/mortality , Cohort Studies , Female , Follow-Up Studies , Humans , Male , Middle Aged , Proportional Hazards Models , Retrospective Studies , Risk Factors , Survival Analysis , Trypanosoma cruzi
SELECTION OF CITATIONS
SEARCH DETAIL
...